Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: a large-scale observational study
Journal
The Lancet Regional Health - Americas
ISSN
2667-193X
Date Issued
2023
Author(s)
Alejandro Jara
Eduardo A. Undurraga
Juan Carlos Flores
José R. Zubizarreta
Cecilia González
Alejandra Pizarro
Duniel Ortuño-Borroto
Acevedo, Johanna
Agencia Nacional de Investigación y Desarrollo, Gobierno de Chile Ministerio de Salud, Johns Hopkins University, Pontificia Universidad Catolica de Chile Escuela de Medicina, Pontificia Universidad Católica de Chile, Universidad de Los Andes, Chile, Universidad del Desarrollo
Katherinne Leo
Fabio Paredes
Tomás Bralic
Verónica Vergara
Francisco Leon
Ignacio Parot
Paulina Leighton
Pamela Suárez
Juan Carlos Rios
Heriberto García-Escorza
Type
Resource Types::text::journal::journal article
URL Institutional Repository
Cite this document
Jara, A., Undurraga, E. A., Flores, J. C., Zubizarreta, J. R., González, C., Pizarro, A., Ortuño-Borroto, D., Acevedo, J., Leo, K., Paredes, F., Bralic, T., Vergara, V., Leon, F., Parot, I., Leighton, P., Suárez, P., Rios, J. C., García-Escorza, H., & Araos, R. (2023). Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: A large-scale observational study. The Lancet Regional Health - Americas, 21, 100487. https://doi.org/10.1016/j.lana.2023.100487
Project(s)
Subjects
covid-19
;
inactivated sars-cov-2 vaccine
;
mrna vaccine
;
paediatric cohort
;
sars-cov-2
;
vaccine effectiveness
;
coronavac
;
inactivated vaccine
;
sars-cov-2 vaccine
;
tozinameran
;
adolescent
;
article
;
child
;
chronic kidney failure
;
coronavirus disease 2019
;
cystic fibrosis
;
drug efficacy
;
female
;
health insurance
;
hospitalization
;
human
;
human immunodeficiency virus infection
;
immunization
;
immunogenicity
;
intensive care unit
;
major clinical study
;
male
;
mass immunization
;
neuropsychological assessment
;
observational study
;
outcome assessment
;
polymerase chain reaction
;
prevalence
;
public health insurance
;
real time polymerase chain reaction
;
social status
;
systemic lupus erythematosus
;
vaccination